This blog from Mark Senak at Eye on FDA is always worth reading and today addresses the digital literacy - or lack of it - within pharma companies. He makes some extremely pertinent comments on the use of digital media such as YouTube to address the lack of patient awareness of clinical trials and their value. I have posted an excerpt below.
Last night FDA Commissioner Andrew Von Eschenbach escaped the Attack of the Killer Tomatoes by coming to California - one of the few States this week where the tomatoes are healthy...
Tags: FDA, Investory Strategy, Product Strategy